Related Experiment Video
Updated: Jul 14, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Invasive Pneumococcal Disease and COVID-19 With Acute Otitis Media and a Tegmen Tympani Defect
Julie Gaudin1, Theepha Thayalakulasingam2
1Internal Medicine, Edward Via College of Osteopathic Medicine, Monroe, USA.
Insights
This case highlights how COVID-19 and incomplete pneumococcal vaccination increase risks for invasive pneumococcal disease (IPD), leading to meningitis and other serious complications. Prompt diagnosis and vaccination are crucial for preventing severe outcomes.
Area of Science:
- Infectious Diseases
- Bacteriology
- Neurology
Background:
- Streptococcus pneumoniae causes severe infections like meningitis, pneumonia, and otitis media, particularly in high-risk individuals.
- Viral infections, including COVID-19, can increase susceptibility to secondary bacterial infections like invasive pneumococcal disease (IPD).
- The interplay between COVID-19 and IPD, especially concerning temporal relationships and neurological complications, requires further investigation.
Observation:
- A 70-year-old female with partial pneumococcal vaccination presented with fever, acute encephalopathy, and COVID-19.
- The patient was diagnosed with IPD, including bacteremia and meningitis, complicated by otitis media and a tegmen tympani defect.
- Clinical course involved sick sinus syndrome, altered mental status, and required pacemaker implantation and myringotomy with tube placement.
Findings:
- Concomitant COVID-19 infection, comorbidities, and incomplete pneumococcal vaccination contributed to the development of IPD and its severe complications.
- Tegmen tympani defects and blood-brain barrier compromise facilitate otogenic intracranial sepsis and meningitis.
- Despite vaccination, IPD remains life-threatening due to challenges in antibiotic penetration to the central nervous system and overlapping symptoms with coinfections.
Implications:
- This case underscores the critical importance of pneumococcal vaccination, even in vaccinated individuals, and maintaining high clinical suspicion for IPD.
- Early diagnosis and treatment of IPD are essential, especially in patients with risk factors and coinfections like COVID-19.
- Understanding the mechanisms of blood-brain barrier damage and routes of infection is vital for managing severe neurological sequelae of IPD.
Abstract:
Streptococcus pneumoniae is a leading cause of otitis media, pneumonia, sinusitis, and meningitis. This encapsulated, gram-positive bacterium colonizes the nasopharynx. Major risk factors, including age, hyposplenism, and immunosuppression, predispose to serious infections. Viral infections are known to increase the risk of secondary bacterial infections as the initial immune response can compromise defenses against bacteria. Coronavirus disease 2019 (COVID-19) similarly poses a risk for secondary bacterial infections and coinfections, such as invasive pneumococcal disease (IPD). Still, temporal relationships between IPD and COVID-19 are not fully understood. IPD may also be a complication of untreated acute otitis media. COVID-19 and pneumococcal bacteremia, a form of IPD, have both been shown to damage the blood-brain barrier and gain access to the central nervous system, resulting in deep infections, namely, meningitis and encephalitis. Presented here is the case of a 70-year-old female partially vaccinated against pneumococcal disease, who was initially evaluated for an elevated temperature, acute encephalopathy, and COVID-19. Further investigation confirmed IPD in the form of bacteremia and meningitis. The patient had a protracted disease course complicated by sick sinus syndrome and altered mental status, which led to the identification of otitis media and a right tegmen tympani defect. Emergent implantation of a single-chamber temporary pacemaker and myringotomy with tube placement was performed. Lumbar puncture showed evidence of meningitis. Antibiotic therapy eventually narrowed to ceftriaxone and continued for a total of six weeks. The presence of comorbidities, history of incomplete pneumococcal vaccination series, and concomitant infection with COVID-19 may explain the development of IPD and other complications seen in this case. Furthermore, tegmen tympani defects and damage to the blood-brain barrier can serve as a route for otogenic intracranial sepsis and meningitis. This case serves to reinforce the importance of pneumococcal vaccination and the high clinical suspicion necessary for the prompt diagnosis and treatment of IPD. However, despite vaccination, IPD remains a life-threatening disease due to poor antibiotic penetration in the central nervous system and overlapping presentations with coinfections, such as COVID-19.
More Related Videos
06:59Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation
Published on: February 29, 2020
03:42High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology
Published on: May 18, 2022
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis II: Management
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.